Condition

Breast Cancer Diagnosis

ClinicalTrials.gov condition label

Clinical trials16

Recruiting3

Common interventions18

Lead sponsors shown14

Clinical trials

16 shown

UCF MammoChat: Image RepositoryNCT07214883 · 2025-09-03

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans AffairsNCT06559059 · 2024-06-18

Institut Paoli Calmettes Breast Cancer DatabaseNCT02869607 · 1995-01-01

Electrochemical Biosensor Based on Lectin-functionalized Nitrogen, Sulfur-doped Graphene Quantum Dot Decorated Gold Nanoparticles for Breast Cancer Diagnosis: From Academic Research to Clinical TranslationNCT07034248 · 2025-07-20

NOT_YET_RECRUITING

Contrast Enhanced Mammography or Breast Magnetic Resonance: Which Choice for Optimal Diagnostic Performance?NCT06843083 · 2025-02-01

ENROLLING_BY_INVITATION

Second-Look Ultrasound Post Contrast-Enhanced Mammography for Additional Lesions CharacterizationNCT06846814 · 2025-01-01

ENROLLING_BY_INVITATION

Contrast Enhanced Mammography in the Evaluation of Cancer of Unknown Primary SyndromeNCT06843096 · 2025-01-01

ENROLLING_BY_INVITATION

A Simplified Approach to Predicting the Malignancy of Breast Lesions: Nomogram in UltrasonographyNCT06185855 · 2023-12-30

Comparison of Low-dose Spiral Breast CT With MRI in Major Indications of MRI for Breast DiagnosticsNCT05989022 · 2023-11-24

Artificial Intelligence for Automated Diagnosis of Breast CancerNCT05858762 · 2020-10-20

A Comparative Study of Mammography and Ultrasound for Breast Cancer Screening and Early DiagnosisNCT04429269 · 2020-06-12

Automated Method for Breast Cancer DetectionNCT03863522 · 2019-03-07

Evaluation of Diagnostic Accuracy of Contrast Enhanced Dual Energy Mammography Imaging in Comparison to CE-MRINCT02608281 · 2015-11-01

Study to Demonstrate the Preliminary Safety and Effectiveness of IPBS in Performing MRI-Guided Targeting and Intervention of Breast Tissue in Female Patients Indicated for MRI-Guided Breast BiopsyNCT01885741 · 2013-09-01

Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer DiagnosisNCT01956409 · 2012-09-01

PMA Required Pivotal Multi-reader Multi-case Reader StudyNCT01952717 · 2012-06-01

Common interventions

CEM protocolDIAGNOSTIC_TEST2 18F-FCHDRUG1 Breast digital tomosynthesisDIAGNOSTIC_TEST1 breast MRIDIAGNOSTIC_TEST1 Cancer Detection cartridgeDEVICE1 CONTRAST ENHANCED DUAL ENERGY (CEDEM)DEVICE1 Contrast-Enhanced Mammography (CEM)DIAGNOSTIC_TEST1 Data collectionOTHER1 Electrochemical biosensorOTHER1 Fine needle aspirationPROCEDURE1 Injection of contrast enhancing agent Gadovist for MRI investigationDIAGNOSTIC_TEST1 Injection of contrast enhancing agent Imeron for B-CT investigationDIAGNOSTIC_TEST1 IPBSDEVICE1 MagnevistDRUG1 mammography and ultrasound screeningDIAGNOSTIC_TEST1 National TeleOncologyBEHAVIORAL1 No InterventionsOTHER1 Retrospective Ultrasonographic Data AnalysisOTHER1

Leading sponsors

Graziella di Grezia3 AB-CT - Advanced Breast-CT GmbH1 Chang Gung Memorial Hospital1 Institut Paoli-Calmettes1 Koning Corporation1 McMaster University1 National Taiwan University Hospital1 NYU Langone Health1 Peking Union Medical College Hospital1 Regina Elena Cancer Institute1 RenJi Hospital1 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1 Siemens Healthcare QT1 University of Central Florida1

Trial status mix

COMPLETED4

UNKNOWN4

ENROLLING_BY_INVITATION3

RECRUITING3

NOT_YET_RECRUITING1

TERMINATED1

Phase mix

NA5

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.